علاج متلازمة إيفانز المتعددة المقاومة للعلاج

References

For patients with multi-refractory ES, targeting long-lived autoreactive plasma cells by means of bortezomib combined with dexamethasone or daratumumab may be a good option.

Another option in the future could also be to use fostamatinib, a spleen tyrosine kinase (syk) inhibitor that has been approved for adult' primary ITP and that has also shown a promising efficacy for wAIHA in a phase II trial.